Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers

unknow

★ 5.0 · 35 reads

Sign in to save this
Request Code
ZLIB.IO18510624
Published
2022
Pages
1
Language
Unknown